Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Anales de Medicina Interna
versión impresa ISSN 0212-7199
Resumen
VARGAS, E. et al. Severe gastrointestinal complications potentially related to the consumption of non-steroidal antiinflammatory drugs: hospital cost due to their treatment for the National Health System in our country. An. Med. Interna (Madrid) [online]. 2001, vol.18, n.11, pp.12-18. ISSN 0212-7199.
Background: Non-steroidal antiinflammatory drugs (NSAIDs) produce severe gastrointestinal (G-I) complications in 1-4% of cases which need to be treated into the hospital. The aim of this study has been to assess the hospital cost secondary to treat these complications in our National Health Service (NHS). Material and methods: In the first phase a cross-sectional study was performed in order to know the number of patients who were hospitalized due to a severe G-I complication during 1998 in two tertiary hospital in our country. It was reviewed their clinical charts to know whether they had taken any NSAIDs. In those positive cases all resources used during the hospitalization were collected. Results: In both hospitals studied 38.1% of hospitalized patients for a severe G-I complication had taken any NSAIDs during the same day or previous days. The cost/patient was of 389,831 pesetas. During 1998 in the whole NHS there were 54,623 hospitalizations owing to the same reason. Assuming that 38.1 % of them had also taken any NSAIDs, 20,811 patients would have suffered a severe G-I complication potentially due to the intake of NSAIDs. Extrapolating the cost/patient obtained in both hospitals to the global number of patients hospitalized into the NHS, the cost of treting all severe G-I complications related to the consumption of NSAIDs during 1998 was of 8,112 millions pesetas Conclusions: Bearing in mind the elevated prevalence of osteo-articular pathology in our country and the high consumption of NSAIDs for its treatment, the coming of new therapeutic options with a better safety profile would mean an important resources' saving for our NHS.
Palabras clave : Severe gastrointestinal complication; Intake of NSAIDs; Hospital cost treatment.